Is the FDA Too Cautious in Its Approach for Approving COVID-19 Vaccines?

Posted on AllSides October 6th, 2020
From The Right
ANALYSIS

"The vaccines are coming momentarily," asserted President Donald Trump in his post-hospitalization video yesterday. The same day the White House reportedly first blocked and then scrambled to approve under pressure the Food and Drug Administration's (FDA) proposed guideline that COVID-19 clinical trial vaccine recipients be followed for two months to evaluate vaccines' safety before they can be approved for inoculating millions of Americans. The justification for first blocking the FDA guidance appears to be that that timeline would make it essentially impossible for a COVID-19 vaccine to be approved by...

Read full story
Some content from this outlet may be limited or behind a paywall.
https://reason.com/2020/10/06/is-the-fda-too-cautious-in-its-approach-for-approving-covid-19-vaccines/

More News about Public Health from the Left, Center and Right

From the Left

From the Center

From the Right